CM Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.35M	Buy	235,000 +10,000	+4%	+$336K	5.31%	2
2025 Q4	$9.64M	Hold	225,000	–	–	8.12%	1
2025 Q3	$6.37M	Sell	225,000 -25,000	-10%	-$748K	5.31%	3
2025 Q2	$4.68M	Hold	250,000	–	–	4.26%	3
2025 Q1	$4.5M	Buy	250,000 +7,500	+3%	+$152K	4.52%	4
2024 Q4	$4.08M	Sell	242,500 -47,500	-16%	-$911K	3.64%	7
2024 Q3	$4.69M	Buy	+290,000	New	+$3.41M	3.74%	5
2024 Q2	–	Sell	-200,000	Closed	-$2.96M	–	68
2024 Q1	$2.96M	Buy	200,000 +30,000	+18%	+$404K	2.49%	13
2023 Q4	$2.46M	Buy	170,000 +20,000	+13%	+$205K	1.98%	15
2023 Q3	$1.62M	Hold	150,000	–	–	1.72%	18
2023 Q2	$1.94M	Hold	150,000	–	–	1.89%	17
2023 Q1	$1.98M	Hold	150,000	–	–	2.35%	12
2022 Q4	$2.25M	Buy	150,000 +20,000	+15%	+$183K	2.69%	14
2022 Q3	$1.53M	Hold	130,000	–	–	1.71%	20
2022 Q2	$1.47M	Buy	130,000 +52,500	+68%	+$1.05M	1.56%	24
2022 Q1	$2.32M	Hold	77,500	–	–	1.95%	16
2021 Q4	$2.05M	Buy	77,500 +2,500	+3%	+$75.4K	1.55%	16
2021 Q3	$2.72M	Hold	75,000	–	–	2.03%	12
2021 Q2	$3.25M	Buy	75,000 +25,000	+50%	+$944K	2.35%	10
2021 Q1	$1.71M	Buy	50,000 +10,000	+25%	+$396K	1.27%	23
2020 Q4	$1.4M	Buy	+40,000	New	+$1.16M	1.3%	26